Andrew A.  Krakauer net worth and biography

Andrew Krakauer Biography and Net Worth

Director of Teleflex
Andrew A. Krakauer serves as Independent Director of the Company. Prior to his retirement in October 2016, Mr. Krakauer was Chief Executive Officer of Cantel Medical Corp. (“Cantel”), a provider of infection control products and services. During his 12 years at Cantel, Mr. Krakauer served in various executive and senior level positions, including Chief Executive Officer from November 2014 to July 2016; President and Chief Executive Officer from March 2009 to November 2014; President from April 2008 to March 2009; and Executive Vice President and Chief Operating Officer from August 2004 through April 2008. Mr. Krakauer also served as a member of Cantel’s board of directors from 2009 to 2016. Prior to joining Cantel, Mr. Krakauer was President of the Ohmeda Medical Division of Instrumentarium Corp. (which was acquired by General Electric Company in 2003), a provider of medical devices, from 1998 to 2004.

What is Andrew A. Krakauer's net worth?

The estimated net worth of Andrew A. Krakauer is at least $178,516.32 as of August 8th, 2018. Mr. Krakauer owns 1,002 shares of Teleflex stock worth more than $178,516 as of December 22nd. This net worth estimate does not reflect any other assets that Mr. Krakauer may own. Learn More about Andrew A. Krakauer's net worth.

How do I contact Andrew A. Krakauer?

The corporate mailing address for Mr. Krakauer and other Teleflex executives is 550 E SWEDESFORD RD, WAYNE PA, 19087. Teleflex can also be reached via phone at (610) 225-6800 and via email at [email protected]. Learn More on Andrew A. Krakauer's contact information.

Has Andrew A. Krakauer been buying or selling shares of Teleflex?

Andrew A. Krakauer has not been actively trading shares of Teleflex during the last quarter. Most recently, on Tuesday, November 30th, Andrew A. Krakauer bought 1,000 shares of Teleflex stock. The stock was acquired at an average cost of $307.23 per share, with a total value of $307,230.00. Learn More on Andrew A. Krakauer's trading history.

Who are Teleflex's active insiders?

Teleflex's insider roster includes Cameron Hicks (VP), Liam Kelly (Chairman, President & CEO), Stephen Klasko (Director), Andrew Krakauer (Director), Thomas Powell (CFO), and Stuart Randle (Director). Learn More on Teleflex's active insiders.

Are insiders buying or selling shares of Teleflex?

During the last year, insiders at the medical technology company sold shares 3 times. They sold a total of 36,331 shares worth more than $8,874,162.70. The most recent insider tranaction occured on August, 16th when Director Stuart A Randle sold 2,674 shares worth more than $638,898.82. Insiders at Teleflex own 1.4% of the company. Learn More about insider trades at Teleflex.

Information on this page was last updated on 8/16/2024.

Andrew A. Krakauer Insider Trading History at Teleflex

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/30/2021Buy1,000$307.23$307,230.00View SEC Filing Icon  
8/8/2018Buy1,000$237.56$237,560.001,002View SEC Filing Icon  
See Full Table

Andrew A. Krakauer Buying and Selling Activity at Teleflex

This chart shows Andrew A Krakauer's buying and selling at Teleflex by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Teleflex Company Overview

Teleflex logo
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
Read More

Today's Range

Now: $178.16
Low: $174.96
High: $179.09

50 Day Range

MA: $202.44
Low: $172.66
High: $239.94

2 Week Range

Now: $178.16
Low: $171.69
High: $256.85

Volume

1,344,395 shs

Average Volume

389,839 shs

Market Capitalization

$8.27 billion

P/E Ratio

35.42

Dividend Yield

0.78%

Beta

1.16